David Owens - 16 Sep 2022 Form 4 Insider Report for Nexalin Technology, Inc. (NXL)

Role
Chief Medical Officer, Director
Signature
/s/ David Owens Name: David Owens, M.D.
Issuer symbol
NXL
Transactions as of
16 Sep 2022
Net transactions value
+$1,000
Form type
4
Filing time
05 Oct 2023, 12:08:46 UTC
Previous filing
19 Sep 2022
Next filing
12 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXL Common stock warrants Purchase $1,000 +2,500 $0.4000 2,500 16 Sep 2022 Common Stock 2,500 $4.15 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.